Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Immungenetics AG logo — company profile

Immungenetics AG

Founded 2009 4 employees Biotechnology

General Information

Company Name Immungenetics AG
Founded Year 2009
Employees 4
Industries Biotechnology
Social

Get notified when Immungenetics AG moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Immungenetics AG

Immungenetics AG is a clinical-stage biopharmaceutical company founded in 2009. Specializing in the Biotechnology industry, the company is dedicated to developing effective treatments for neurodegenerative diseases. As a venture capital firm, it is crucial to keep an eye on Immungenetics AG's progress, especially in the field of neurodegenerative disease treatments, as it signifies potential breakthroughs in the healthcare sector. With a focus on cutting-edge research and development, Immungenetics AG holds promise for significant advancements in the treatment of neurodegenerative conditions. Although details about their headquarters and last investment are currently undisclosed, their innovative approach to combating neurodegenerative diseases makes them a compelling prospect for potential investment opportunities in the biopharmaceutical sector.

Taxonomy: Biopharmaceutical, Neurodegenerative diseases, Clinical-stage, ABC transporters, Blood-brain barrier, Therapeutic targeting, Central Nervous System, Drug development, Drug delivery, Neurology, Medical research

No funding data available for Immungenetics AG yet.

Get notified when Immungenetics AG raises funding

Immungenetics AG Alternatives & Competitors

Immungenetics AG vs
Bostal Drug Delivery
Bostal Drug Delivery

Innovative drug delivery solutions enhancing the development and improvement of pharmaceuticals sinc...

Series B
Biotechnology, Health Care
Immungenetics AG vs
Congruence Medical Solutions
Congruence Medical Solutions United States

Addressing compelling needs in injectable drug delivery

8 employees
Immungenetics AG vs
National Drug Screening, Inc.
National Drug Screening, Inc. United States

Drug and alcohol testing programs for large and small employers.

21 employees
Biotechnology, Health Care

FAQ About Immungenetics AG

Immungenetics AG is a clinical-stage biopharmaceutical company, developing effective treatments for neurodegenerative diseases.
Immungenetics AG was founded in 2009.
Immungenetics AG operates in the following industries: Biotechnology.
Immungenetics AG has approximately 4 employees.
Top alternatives and competitors to Immungenetics AG include Bostal Drug Delivery, Congruence Medical Solutions, National Drug Screening, Inc., METiS Pharmaceuticals, Forensic Fluids Laboratories. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Immungenetics AG and Bostal Drug Delivery are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Immungenetics AG and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy